2) zinc transporter
锌转运体
1.
Eukaryotic zinc transporters and their regulation;
真核生物锌转运体及其活性的调控
2.
Objective To determine the effect of dietary zinc supplement on the expression of zinc transporters in breast cancer cells in a nude mice model;To study the changes of zinc transporter gene expression in human breast cancer cell lines MCF-7 and MDA-MB-231 exposed to ZnCl_2 and TPEN;And to explore the possible mechanisms associated with zinc and zinc transporters in human breast cancer.
研究目的: 通过建立人乳腺癌裸鼠移植瘤模型来观察饮食锌对锌转运体在乳腺癌中表达的影响;细胞水平观察高锌、低锌状态下乳腺癌细胞株MCF-7和MDA-MB-231锌转运体的表达情况。
3.
In the recent years,the studies on the zinc transporters help people to reveal the biological functions of zinc.
近年来人们对锌转运体(zinctransporters,ZNTs)的研究进一步揭示了锌的生物学功能,ZNT7就是其中一个重要组成成员,它的功能是将锌转运到高尔基体内,从而维持细胞内的锌稳态。
3) transporter
[英][træn'spɔ:tə(r)] [美][træn'spɔrtɚ]
转运体
1.
Localization of GABA transporter and its associated gene at the blood-brain barrier;
血脑屏障上γ-氨基丁酸转运体及其相关基因的分布
2.
Localization of GABA transporter subtypes at the blood-brain barrier;
血脑屏障上GABA转运体亚型的分布
3.
Effect of emodin on transporter gene expression of hepatocytes in intrahepatic cholestatic rats
大黄素对胆汁淤积大鼠肝细胞转运体基因表达的影响
5) half-transporter
半转运体
6) Transporter
[英][træn'spɔ:tə(r)] [美][træn'spɔrtɚ]
转运载体
1.
The classification of C4-dicarboxylate transporter,the expression and regulation of C4-dicarboxylate transport genes,and the importance of C4-dicarboxylate transport system for nitrogen fixation were reviewed in the paper.
四碳二羧酸是细菌重要的碳源与能源物质,四碳二羧酸的转运需要细菌四碳二羧酸转运载体的参与。
2.
Small intestinal segments samples were collected from duodenum,proximal and distal jejunums,ileum for detection intestinal tissue distribution of oligopeptide transporter PepT1,anionic amino acid transporter EAAC1 and cationic amino acid transporter CAT1 mRNA abundance by Real-time PCR.
选取体重接近且健康的28日龄哺乳仔藏猪6头,屠宰后分离肠道(十二指肠、空肠前段、空肠后段和回肠),运用RFQ-PCR技术对藏猪不同肠段小肽转运载体PepT1、酸性氨基酸转运载体EAAC1和碱性氨基酸转运载体CAT1 mRNA的组织分布进行研究。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条